METASTATIC UROTHELIAL CARCINOMA
Clinical trials for METASTATIC UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to shield patients from chemo side effects in bladder cancer battle
Disease control Not yet recruitingThis early-stage study is testing whether adding an investigational drug called GB-4362 to a standard two-drug regimen can make treatment safer for adults with advanced bladder cancer. GB-4362 is designed to neutralize a specific chemotherapy component that causes side effects li…
Matched conditions: METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Massive 3,000-Patient study to track Real-World bladder cancer treatment outcomes
Knowledge-focused Not yet recruitingThis study will analyze existing medical records to understand how long advanced bladder cancer treatments work in real-world settings and which medications doctors most commonly prescribe. Researchers will examine data from 3,000 adult patients who received standard care from th…
Matched conditions: METASTATIC UROTHELIAL CARCINOMA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Apr 04, 2026 03:51 UTC